GIM
TMO icon

Glenmede Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Glenmede Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$41M Sell
84,444
-29,195
-26% -$13.6M 0.2% 96
2025
Q2 		$46.1M Buy
+113,639
New +$47.5M 0.23% 88

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Glenmede Investment Management's TMO Position: Q3 2025 in Review

Glenmede Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q3 2025, selling an estimated $13.6M and leaving 84,444 shares worth $41M. The position accounts for 0.2% of the portfolio, ranked #96.

Glenmede Investment Management first reported a position in TMO in Q2 2025 and has held it in 2 quarters since. The position peaked at $46.1M in Q2 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Glenmede Investment Management held 84,444 shares of Thermo Fisher Scientific worth $41M as of Q3 2025.
  • Glenmede Investment Management sold 29,195 Thermo Fisher Scientific shares in Q3 2025, an estimated $13.6M.
  • Thermo Fisher Scientific made up 0.2% of Glenmede Investment Management's portfolio in Q3 2025, its #96 holding.
  • Glenmede Investment Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Thermo Fisher Scientific position peaked at $46.1M in Q2 2025.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.